{"entity":{"id":"nct06073938","kind":"trial","name":"Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement","aka":[],"tldr":"An trial of NHWD-870 run by Hunan Province Tumor Hospital, of unknown status on the registry.","summary":"Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement is an interventional study registered as NCT06073938 by Hunan Province Tumor Hospital, with 30 participants planned, started 2022-09-20. Conditions recorded: Advanced Solid Tumors or Lymphomas. Interventions recorded: NHWD-870.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06073938","url":"https://clinicaltrials.gov/study/NCT06073938"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["nhwd-870"],"companies":["zhejiang-wenda-pharma"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06073938","phase":"not-applicable","setting":"A Real-World Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement","sponsor":"Hunan Province Tumor Hospital","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06073938/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"nhwd-870","kind":"drug","name":"NHWD-870","route":"/drugs/nhwd-870/"}],"company":[{"id":"zhejiang-wenda-pharma","kind":"company","name":"Zhejiang Wenda Pharma","route":"/companies/zhejiang-wenda-pharma/"}]}}